GL BIOPHARMACEUTICALS INCORPORATION LIMITED

GL BIOPHARMACEUTICALS INCORPORATION LIMITED focuses on developing new antibacterial drugs to combat infections caused by multidrug-resistant Gram-negative bacteria. As antimicrobial resistance (AMR) increases, global healthcare systems face significant challenges. Our mission is to provide effective treatment solutions through innovative research and development to save lives.

We employ a drug repurposing strategy to develop oral therapies for infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP). Our core team consists of experienced drug development experts and clinical researchers who actively collaborate with multiple hospitals to conduct clinical trials and validate the effectiveness of our treatment plans. We are committed to advancing the development of Class II new drugs and innovating combination therapies to reduce the use of antibiotics, providing solutions to the problem of antimicrobial resistance.

Key Team Members

CHEN Kai-chao (Department of Food Science and Nutrition)
Prof. CHEN Sheng (Department of Food Science and Nutrition)
Dr XIE Miao-miao (Department of Food Science and Nutrition)
Dr ZHANG Bing (Department of Food Science and Nutrition)
Dr NI Hong-yu-hang